Matches in SemOpenAlex for { <https://semopenalex.org/work/W1893749241> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W1893749241 endingPage "2920" @default.
- W1893749241 startingPage "2917" @default.
- W1893749241 abstract "A 53-year-old woman with left breast tumor was diagnosed as bilateral breast cancer(left; T3N3M0, Stage III C/right; T2N0M0, Stage II )in our hospital, both of which were revealed as invasive ductal carcinoma shown to be ER-negative, PgR negative and HER2-positive by core needle biopsy. In December 2004, paclitaxel and trastuzumab combination therapy was tried, but she went into shock just during administration of paclitaxel, and this therapy was discontinued. After that the triweekly CTF therapy was tried as an anthracycline containing regimen, and the lymph node metastases obtained a complete response after a month and a 38. 5% reduction of left primary breast tumor, which was the best response observed after three months. Time to progression was prolonged to 7 months(9 cycles). Although febrile neutropenia occurred in the first cycle, the therapy could be continued safely thereafter as an outpatient. Anthracycline-containing regimens are likely to be avoided because of the difficulty of combining with trastuzumab in the treatment of HER2 overexpressing advanced/metastatic breast cancer. But the CTF therapy of less cardiotoxicity and less alopecia, can expect longer use and better QOL as an alternative for HER2 overexpressing advanced/metastatic breast cancer patients." @default.
- W1893749241 created "2016-06-24" @default.
- W1893749241 creator A5011246432 @default.
- W1893749241 creator A5019828324 @default.
- W1893749241 creator A5028938734 @default.
- W1893749241 creator A5034408095 @default.
- W1893749241 creator A5048191593 @default.
- W1893749241 creator A5060375630 @default.
- W1893749241 creator A5066487179 @default.
- W1893749241 creator A5067284524 @default.
- W1893749241 creator A5069396542 @default.
- W1893749241 creator A5071820618 @default.
- W1893749241 creator A5071839885 @default.
- W1893749241 creator A5075754635 @default.
- W1893749241 creator A5085258127 @default.
- W1893749241 date "2010-12-01" @default.
- W1893749241 modified "2023-09-27" @default.
- W1893749241 title "[A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock]." @default.
- W1893749241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21160270" @default.
- W1893749241 hasPublicationYear "2010" @default.
- W1893749241 type Work @default.
- W1893749241 sameAs 1893749241 @default.
- W1893749241 citedByCount "0" @default.
- W1893749241 crossrefType "journal-article" @default.
- W1893749241 hasAuthorship W1893749241A5011246432 @default.
- W1893749241 hasAuthorship W1893749241A5019828324 @default.
- W1893749241 hasAuthorship W1893749241A5028938734 @default.
- W1893749241 hasAuthorship W1893749241A5034408095 @default.
- W1893749241 hasAuthorship W1893749241A5048191593 @default.
- W1893749241 hasAuthorship W1893749241A5060375630 @default.
- W1893749241 hasAuthorship W1893749241A5066487179 @default.
- W1893749241 hasAuthorship W1893749241A5067284524 @default.
- W1893749241 hasAuthorship W1893749241A5069396542 @default.
- W1893749241 hasAuthorship W1893749241A5071820618 @default.
- W1893749241 hasAuthorship W1893749241A5071839885 @default.
- W1893749241 hasAuthorship W1893749241A5075754635 @default.
- W1893749241 hasAuthorship W1893749241A5085258127 @default.
- W1893749241 hasConcept C121608353 @default.
- W1893749241 hasConcept C126322002 @default.
- W1893749241 hasConcept C143998085 @default.
- W1893749241 hasConcept C2776085618 @default.
- W1893749241 hasConcept C2776694085 @default.
- W1893749241 hasConcept C2776755627 @default.
- W1893749241 hasConcept C2776802502 @default.
- W1893749241 hasConcept C2778233292 @default.
- W1893749241 hasConcept C2779786085 @default.
- W1893749241 hasConcept C2781303535 @default.
- W1893749241 hasConcept C2781413609 @default.
- W1893749241 hasConcept C530470458 @default.
- W1893749241 hasConcept C71924100 @default.
- W1893749241 hasConceptScore W1893749241C121608353 @default.
- W1893749241 hasConceptScore W1893749241C126322002 @default.
- W1893749241 hasConceptScore W1893749241C143998085 @default.
- W1893749241 hasConceptScore W1893749241C2776085618 @default.
- W1893749241 hasConceptScore W1893749241C2776694085 @default.
- W1893749241 hasConceptScore W1893749241C2776755627 @default.
- W1893749241 hasConceptScore W1893749241C2776802502 @default.
- W1893749241 hasConceptScore W1893749241C2778233292 @default.
- W1893749241 hasConceptScore W1893749241C2779786085 @default.
- W1893749241 hasConceptScore W1893749241C2781303535 @default.
- W1893749241 hasConceptScore W1893749241C2781413609 @default.
- W1893749241 hasConceptScore W1893749241C530470458 @default.
- W1893749241 hasConceptScore W1893749241C71924100 @default.
- W1893749241 hasIssue "13" @default.
- W1893749241 hasLocation W18937492411 @default.
- W1893749241 hasLocation W18937492412 @default.
- W1893749241 hasOpenAccess W1893749241 @default.
- W1893749241 hasPrimaryLocation W18937492411 @default.
- W1893749241 hasVolume "37" @default.
- W1893749241 isParatext "false" @default.
- W1893749241 isRetracted "false" @default.
- W1893749241 magId "1893749241" @default.
- W1893749241 workType "article" @default.